BioSpace News Archive

Initial Global Use of the Aquilion Precision has Demonstrated Significantly Increased Visibility of Small Anatomical Structures

Worldwide Clinical Trials, Inc. announced that Philippa Marshall, MD, BSc, FFPM, has joined the company as Vice President, Scientific Solutions, focused on immune-mediated inflammatory disorders.

Three-year collaboration to catalyze novel science and technology solutions to expand healthy longevity and eliminate diseases around the world

McKesson Corporation announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical and Specialty Solutions business.

Hagens Berman Sobol Shapiro LLP reminds investors in Diplomat Pharmacy, Inc. of the pending securities class action and the April 25, 2019 Lead Plaintiff deadline.

The collaboration will evaluate the safety and efficacy of Tessa’s armored human papillomavirus-specific T cell (HPVST) therapy combined with Merck’s KEYTRUDA® (pembrolizumab) to address the limited number of effective treatment options for metastatic or recurrent cervical cancer

The Company Joins the Bleeding Disorder’s Community to Celebrate

Athletico Physical Therapy has opened a new location in Lenexa on Monday, April 15th and is conveniently located at the intersection off of 87th Street Parkway.

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 28,000 shares of Pulse Biosciences common stock to three new non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on April 15, 2019.

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2019 on Wednesday, May 8, 2019, following the close of the market.